University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

dc.contributor.authorStanley, Brooklyn
dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorBourdin, Arnaud
dc.contributor.authorCanonica, Giorgio Walter
dc.contributor.authorGurnell, Mark
dc.contributor.authorReddel, Helen K.
dc.contributor.authorHeaney, Liam G
dc.contributor.authorCarter, Victoria
dc.contributor.authorChapaner, Jatin
dc.contributor.authorTran, Trung N
dc.contributor.authorMaslova, Ekaterina
dc.contributor.authorMaslova, Ekaterina
dc.contributor.authorPrice, David
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2023-09-03T23:30:26Z
dc.date.available2023-09-03T23:30:26Z
dc.date.embargoedUntil2023-09-04
dc.date.issued2022-08-01
dc.description.statusPeer revieweden
dc.format.extent368966
dc.identifier218506399
dc.identifierff0156b9-0cc3-46e7-9f98-8824c2a8e9c7
dc.identifier.citationStanley, B, Menzies-Gow, A, Bourdin, A, Canonica, G W, Gurnell, M, Reddel, H K, Heaney, L G, Carter, V, Chapaner, J, Tran, T N, Maslova, E, Maslova, E & Price, D 2022, 'Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma', European Respiratory Society (ERS) International Congress., Barcelona, Spain, 4/09/22 - 6/09/22.en
dc.identifier.citationconferenceen
dc.identifier.urihttps://hdl.handle.net/2164/21610
dc.language.isoeng
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleOral corticosteroid (OCS) risk predictor for Type II Diabetes in asthmaen
dc.typeConference itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Stanley_etal_ERS_Oral_Corticosteroid_AAM.pdf
Size:
360.32 KB
Format:
Adobe Portable Document Format

Collections